Learn More - WordPress theme developed by myThem.es

Diarrhea Troublesome Side Effect Among HIV+; Mytesi Could Help

By: Winnie McCroy, EDGE Media Network Editor

There is clear evidence that diarrhea among HIV-positive patients is under-recognized and underreported. A new study by Patrick Clay, Pharm.D, reveals that HIV patients experience and self-medicate GI-symptoms, such as diarrhea, without their doctor’s knowledge — the study used ‘real world’ data comparing healthcare providers’ perceptions and clinical records to their patients’ perceptions of ART tolerability and self-management.

Read More

HIV antidiarrheal Mytesi

By: Positively Aware (NOV+DEC 2016)

Previously known as Fulyzaq (generic name crofelemer), the only FDA-approved drug for treating HIV-related diarrhea has been acquired by Napo Pharmaceuticals and is now marketed under the name Mytesi. The company has launched patient co-pay and patient assistance programs to allow for broader access to Mytesi. For details, go to mytesi.com/mytesi-savings.html.

Read More
Optimization WordPress Plugins & Solutions by W3 EDGE